DeepMed Research

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Local Anesthesia for Facial Fractures

Phase 2

Recruiting

Conditions: Pain Management

Interventions: Drug: Bupivacaine/Epinephrine
Drug: Saline

First Posted Date: 2024-05-28

Last Posted Date: 2024-05-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 70

Registration Number: NCT06429501

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation

Phase 2

Terminated

Conditions: Alzheimers Disease, Familial
Dementia
Alzheimers Disease

Interventions: Drug: Gantenerumab

First Posted Date: 2024-05-22

Last Posted Date: 2025-02-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 73

Registration Number: NCT06424236

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
University of Alabama in Birmingham, Birmingham, Alabama, United States
🇺🇸
University of California San Diego Medical Center, La Jolla, California, United States

and more 14 locations

Block and Periarticular Injection Study

Phase 4

Conditions: Pain, Postoperative

Interventions: Drug: PAI
Drug: regional anesthesia and PAI

First Posted Date: 2024-05-13

Last Posted Date: 2024-05-13

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 200

Registration Number: NCT06410612

Locations: 🇺🇸
Washington University School of Medicine, Creve Coeur, Missouri, United States

Rivastigmine to Prevent Recurrence of Antimuscarinic Delirium

Phase 2

Recruiting

Conditions: Anticholinergic Toxicity

Interventions: Drug: Placebo
Drug: Rivastigmine

First Posted Date: 2024-05-06

Last Posted Date: 2024-11-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 42

Registration Number: NCT06399679

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Peanut-based School Meals in Rural Ghana to Improve Attendance and Retention

Not Applicable

Conditions: Child Nutrition
School Enrollment
School Attendance
School Dropouts
School Feeding Programs

Interventions: Dietary Supplement: Ready-to-use school food
Dietary Supplement: Standard meal

First Posted Date: 2024-05-03

Last Posted Date: 2024-12-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 5500

Registration Number: NCT06397989

Locations: 🇬🇭
Bofoyili E/P JHS, Bofoyili, Ghana
🇬🇭
Jimle/Guma R/C primary school, Jimle, Ghana
🇬🇭
Kpuligini Islamic primary school, Kpuligini, Ghana

and more 17 locations

Evaluation of a Novel Technology to Support Tailored Health Behavior Counseling in Rural Primary Care Clinics

Not Applicable

Not yet recruiting

Conditions: Cardiovascular Diseases
Obesity

Interventions: Behavioral: Wait-List Control
Behavioral: PREVENT Tool

First Posted Date: 2024-05-03

Last Posted Date: 2024-05-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 100

Registration Number: NCT06397729

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

LIMIT Trial - Lidocaine With Intramuscular Injection of Benzathine Penicillin G for Treponema Pallidum Treatment

Phase 3

Recruiting

Conditions: Benzathine Penicillin Adverse Reaction
Syphilis Infection

Interventions: Drug: normal Saline
Drug: Lidocaine

First Posted Date: 2024-04-30

Last Posted Date: 2025-03-25

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 48

Registration Number: NCT06391125

Locations: 🇺🇸
WashU Infectious Diseases Clinic, Saint Louis, Missouri, United States

DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease

Phase 3

Recruiting

Conditions: Dementia
Alzheimer's Disease, Familial
Alzheimer's Disease

Interventions: Drug: lecanemab

First Posted Date: 2024-04-25

Last Posted Date: 2025-04-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 65

Registration Number: NCT06384573

Locations: 🇺🇸
University of Alabama in Birmingham, Birmingham, Alabama, United States
🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States
🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

and more 3 locations

Rivastigmine for Antimuscarinic Delirium

Phase 2

Not yet recruiting

Conditions: Anticholinergic Toxicity

Interventions: Drug: Placebo
Drug: Rivastigmine

First Posted Date: 2024-04-24

Last Posted Date: 2024-11-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 42

Registration Number: NCT06382649

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

Phase 1

Recruiting

Conditions: Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer

Interventions: Drug: Zumsemetinib
Drug: Capecitabine
Drug: Zoledronic acid
Drug: Denosumab

First Posted Date: 2024-04-18

Last Posted Date: 2025-02-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 152

Registration Number: NCT06374459

Locations: 🇺🇸
The University of Kansas Cancer Center, Westwood, Kansas, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy